NCT06633666 Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
| NCT ID | NCT06633666 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Baptist University |
| Condition | Long Covid19 |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2023-07-30 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2023-07-30 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
Eligibility Criteria
Inclusion Criteria: * meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with Covid-19, and continue to have at least one neuropsychiatric symptom for 2 months after SARS-CoV-2 turned negative 3 months above; * aged 12 to 80 years; * willing and able to consent, and complete all assessment and study procedures Exclusion Criteria: * patients with a history of chronic neuropsychiatric symptoms; * cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers; * documented pre-existing history of psychiatric illness, including substance abuse; * suicidal tendencies (attempted suicide in the 12 months before the study); * any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor); * those who participated in other clinical trials within one month; * pregnant or lactating female patients; * have surgery within two months before the study or will have a scheduled surgery during the study; * acute brain injury or acute encephalopathy from another etiology than Covid-19 (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity); * open-heart cardiac surgery or cardiac arrest during the last 6 months; * patients who received acupuncture treatment 1 month before the start of the study; * patients who were unable to complete the assessment during screening due to severe mental, cognitive, or emotional impairment
Contact & Investigator
Dong Jue Wei, MD.
STUDY CHAIR
Hong Kong Baptist University
Frequently Asked Questions
Who can join the NCT06633666 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Long Covid19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06633666 currently recruiting?
Yes, NCT06633666 is actively recruiting participants. Contact the research team at ldzhong0305@gmail.com for enrollment information.
Where is the NCT06633666 trial being conducted?
This trial is being conducted at Kowloon Tong, Hong Kong.
Who is sponsoring the NCT06633666 clinical trial?
NCT06633666 is sponsored by Hong Kong Baptist University. The principal investigator is Dong Jue Wei, MD. at Hong Kong Baptist University. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.